Vanguard Fiduciary Trust
IMMX icon

Vanguard Fiduciary Trust’s Immix Biopharma IMMX Stock Holding History

Vanguard Fiduciary Trust’s Portfolio IMMX Stock Details IMMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.19M Buy
406,032
+153,118
+61% +$1.42M ﹤0.01% 2285
2026
Q1 		$2.3M Buy
+252,914
New +$1.86M ﹤0.01% 2493

Other funds holding IMMX

JT
Jupiter Topco New York $245B AUM
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vanguard Fiduciary Trust's IMMX Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its Immix Biopharma (IMMX) stake by 61% in Q2 2026, buying an estimated $1.42M and bringing the position to 406,032 shares worth $4.19M. The position accounts for ﹤0.01% of the portfolio, ranked #2285.

Vanguard Fiduciary Trust first reported a position in IMMX in Q1 2026 and has held it in 2 quarters since. 109 funds tracked by Wall St. Rank hold IMMX as of Q2 2026.

  • Vanguard Fiduciary Trust held 406,032 shares of Immix Biopharma worth $4.19M as of Q2 2026.
  • Vanguard Fiduciary Trust bought 153,118 Immix Biopharma shares in Q2 2026, an estimated $1.42M.
  • Immix Biopharma made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #2285 holding.
  • Vanguard Fiduciary Trust first reported a position in Immix Biopharma in Q1 2026 and has held it in 2 quarters since.
  • 109 funds tracked by Wall St. Rank held Immix Biopharma as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.